India Reports One-Third of Global Cervical Cancer Cases: Why HPV Vaccination Offers Hope

ରାଶିଫଳ

ସାପ୍ତାହିକ ରାଶିଫଳ: ୭ ସେପ୍ଟେମ୍ବରରୁ ୧୪ ସେପ୍ଟେମ୍ବର ୨୦୨୬

September 07, 2026

ଓଡିଶା

୩୦ ବର୍ଷ ହେଲା ବନ୍ୟା ଘେରରେ ସ୍କୁଲ, ସାହି କୋଠଘରେ...

September 07, 2026

ଦାଦନ ଖଟିବାକୁ ଯାଇଥିଲେ, ଫେରିଲା ମୃତଦେହ; ୧୯ ବର୍ଷୀୟ ଚନ୍ଦ୍ରଙ୍କ...

September 07, 2026

ଜିଲ୍ଲାପାଳଙ୍କ ଜନଶୁଣାଣିରେ ଅଭାବନୀୟ ଘଟଣା, କୀଟନାଶକ ପିଇବାକୁ ୫ ଜଣଙ୍କ...

September 07, 2026

ସ୍କୁଲ ଯାଉଥିବା ଛାତ୍ରଙ୍କୁ ତୀରମାଡ଼ ଅଭିଯୋଗ, ବ୍ୟାଗ ଭେଦି ଚାଲିଗଲା...

September 07, 2026

India Reports One-Third of Global Cervical Cancer Cases: Why HPV Vaccination Offers Hope

India accounts for about one-third of the world’s cervical cancer burden, with tens of thousands of women affected each year — a largely preventable disease. The upcoming nationwide HPV vaccination programme aims to curb new cases and save lives by providing early protection to adolescent girls.

Published by Somesh | February 24, 2026

India continues to carry adisproportionately high burden of cervical cancer, accounting for roughlyone-third of global cases— making it one of the most pressing women’s health challenges in the country. Cervical cancer, caused mainly by persistent infection withhigh-risk human papillomavirus (HPV)types such as 16 and 18, is among the most common yet preventable cancers affecting women worldwide.

In response to this heavy disease burden, theGovernment of Indiais preparing to launch anationwide HPV vaccination programmeaimed at protecting adolescent girls before potential exposure to the virus. The initiative will use theGardasil quadrivalent vaccine, which guards against the HPV strains responsible for the majority of cervical cancer cases, and is being introducedfree of cost and on a voluntary basisunder the Universal Immunisation Programme.

Medical and public health experts highlight thatHPV vaccines are among the most effective toolsfor preventing cervical cancer, showing over90 % effectivenessagainst infection by vaccine-covered HPV types in numerous global studies. Administering the vaccine to girls around14 years of age— before sexual debut — offers thegreatest long-term protectionand aligns with guidelines from theWorld Health Organization (WHO)on cervical cancer elimination strategies.

With India joining more than160 countriesthat have incorporated HPV vaccination into their national immunisation schedules, health officials hope the programme will significantly reduceboth incidence and mortalityfrom cervical cancer over time. This public health push, combined with broader awareness and screening efforts, offers a ray of hope for millions of women and marks a crucial step toward curbing a largely preventable form of cancer.